Recent preclinical studies have explored some novel antioxidant therapeutic compounds for PTSD, including those that target potassium channels [38], glucocorticoid receptor pathways [39], and drug candidates targeting brain-derived neurotrophic factor (BDNF) and tropomyosin receptor kinase B (TrkB) signaling [40]. Here, BDNF is linked to post-traumatic stress disorder.